Organised Data Collection Systems (ODCS) are essential to pharmacovigilance, ensuring systematic, comprehensive, and reliable data collection to monitor and improve drug safety.

In the pharmaceutical industry, ensuring the safety and efficacy of drugs is paramount. This responsibility is shared between various departments, with Quality Assurance (QA) and Pharmacovigilance (PV) playing crucial roles. While Pharmacovigilance focuses on monitoring and assessing adverse drug reactions, the QA department ensures that the processes involved in drug production and monitoring meet stringent quality standards. The intersection of these two functions is critical for maintaining drug safety and regulatory compliance.

Not all sunscreens are created equal, and ensuring their safety and efficacy falls under the purview of the Therapeutic Goods Administration (TGA).

Event coding in PV stands out as a critical process. A systematic and standardised approach to coding adverse events and medical terms is essential for efficient signal detection, risk management and regulatory reporting.